ES3065721T3 - Monoacylglycerol lipase modulators - Google Patents

Monoacylglycerol lipase modulators

Info

Publication number
ES3065721T3
ES3065721T3 ES21705124T ES21705124T ES3065721T3 ES 3065721 T3 ES3065721 T3 ES 3065721T3 ES 21705124 T ES21705124 T ES 21705124T ES 21705124 T ES21705124 T ES 21705124T ES 3065721 T3 ES3065721 T3 ES 3065721T3
Authority
ES
Spain
Prior art keywords
azabicyclo
azaspiro
carbonyl
octan
oxa
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES21705124T
Other languages
English (en)
Spanish (es)
Inventor
Michael K Ameriks
Cynthia B Berry
Pablo Garcia-Reynaga
Brian Ngo Laforteza
Jimmy T Liang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceutica NV
Original Assignee
Janssen Pharmaceutica NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica NV filed Critical Janssen Pharmaceutica NV
Application granted granted Critical
Publication of ES3065721T3 publication Critical patent/ES3065721T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/423—Oxazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/08—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing alicyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/08—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing alicyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/08—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing alicyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
ES21705124T 2020-02-10 2021-02-09 Monoacylglycerol lipase modulators Active ES3065721T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202062972484P 2020-02-10 2020-02-10
PCT/EP2021/053062 WO2021160602A1 (en) 2020-02-10 2021-02-09 Monoacylglycerol lipase modulators

Publications (1)

Publication Number Publication Date
ES3065721T3 true ES3065721T3 (en) 2026-05-07

Family

ID=74595268

Family Applications (1)

Application Number Title Priority Date Filing Date
ES21705124T Active ES3065721T3 (en) 2020-02-10 2021-02-09 Monoacylglycerol lipase modulators

Country Status (23)

Country Link
US (2) US11708359B2 (cg-RX-API-DMAC7.html)
EP (1) EP4103557B1 (cg-RX-API-DMAC7.html)
JP (1) JP7795466B2 (cg-RX-API-DMAC7.html)
KR (1) KR20220140581A (cg-RX-API-DMAC7.html)
CN (1) CN115066422B (cg-RX-API-DMAC7.html)
AR (1) AR121296A1 (cg-RX-API-DMAC7.html)
AU (1) AU2021220539A1 (cg-RX-API-DMAC7.html)
BR (1) BR112022015116A2 (cg-RX-API-DMAC7.html)
CA (1) CA3169988A1 (cg-RX-API-DMAC7.html)
CL (1) CL2022002136A1 (cg-RX-API-DMAC7.html)
CO (1) CO2022011275A2 (cg-RX-API-DMAC7.html)
CR (1) CR20220376A (cg-RX-API-DMAC7.html)
DO (1) DOP2022000162A (cg-RX-API-DMAC7.html)
EC (1) ECSP22062460A (cg-RX-API-DMAC7.html)
ES (1) ES3065721T3 (cg-RX-API-DMAC7.html)
IL (1) IL295447A (cg-RX-API-DMAC7.html)
JO (1) JOP20220180A1 (cg-RX-API-DMAC7.html)
MX (1) MX2022009804A (cg-RX-API-DMAC7.html)
PE (1) PE20221576A1 (cg-RX-API-DMAC7.html)
PH (1) PH12022552019A1 (cg-RX-API-DMAC7.html)
TW (1) TW202140465A (cg-RX-API-DMAC7.html)
UY (1) UY39066A (cg-RX-API-DMAC7.html)
WO (1) WO2021160602A1 (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20221576A1 (es) 2020-02-10 2022-10-06 Janssen Pharmaceutica Nv Moduladores de la monoacilglicerol lipasa
KR20220158008A (ko) 2020-03-26 2022-11-29 얀센 파마슈티카 엔.브이. 모노아실글리세롤 리파아제 조절제로서의 아자스피로사이클
CA3176113A1 (en) 2020-03-26 2021-09-30 Janssen Pharmaceutica Nv Aminocyclobutanes as monoacylglycerol lipase modulators
CA3177058A1 (en) 2020-03-26 2021-09-30 Janssen Pharmaceutica Nv Aryl piperidines as monoacylglycerol lipase modulators
US12115154B2 (en) 2020-12-16 2024-10-15 Srx Cardio, Llc Compounds for the modulation of proprotein convertase subtilisin/kexin type 9 (PCSK9)
EP4384165B1 (en) 2021-08-09 2025-07-09 Janssen Pharmaceutica NV Monoacylglycerol lipase modulators for use in autism spectrum disorders
IL313987A (en) 2021-12-29 2024-08-01 Psy Therapeutics Inc Inhibiting monoacylglycerol lipase (magl)

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA05000945A (es) 2002-07-25 2005-05-16 Pharmacia Italia Spa Biciclo-pirazoles activos como inhibidores de la cinasa, procedimientos para su preparacion y composiciones farmaceuticas que los contienen.
EP2090576A1 (en) 2008-02-01 2009-08-19 Merz Pharma GmbH & Co.KGaA 6-halo-pyrazolo[1,5-a]pyridines, a process for their preparation and their use as metabotropic glutamate receptor (mGluR) modulators
EP2760450A1 (en) * 2011-09-30 2014-08-06 Janssen Pharmaceutica, N.V. Monoacylglycerol lipase inhibitors for the treatment of metabolic diseases and related disorders
WO2017170830A1 (ja) 2016-03-31 2017-10-05 武田薬品工業株式会社 複素環化合物
UY37174A (es) 2016-03-31 2017-10-31 Takeda Pharmaceuticals Co Un compuesto heterocíclico que tiene una acción inhibidora de monoacilglicerol lipasa
GB201613163D0 (en) * 2016-07-29 2016-09-14 Autifony Therapeutics Ltd Novel compounds
AU2018338855B2 (en) 2017-09-29 2022-04-28 Takeda Pharmaceutical Company Limited Heterocyclic compound
CN112272670B (zh) 2019-04-16 2023-12-12 上海翰森生物医药科技有限公司 含二并环类衍生物抑制剂、其制备方法和应用
PE20221576A1 (es) 2020-02-10 2022-10-06 Janssen Pharmaceutica Nv Moduladores de la monoacilglicerol lipasa
KR20220158008A (ko) 2020-03-26 2022-11-29 얀센 파마슈티카 엔.브이. 모노아실글리세롤 리파아제 조절제로서의 아자스피로사이클
CA3176113A1 (en) 2020-03-26 2021-09-30 Janssen Pharmaceutica Nv Aminocyclobutanes as monoacylglycerol lipase modulators
CA3177058A1 (en) 2020-03-26 2021-09-30 Janssen Pharmaceutica Nv Aryl piperidines as monoacylglycerol lipase modulators

Also Published As

Publication number Publication date
ECSP22062460A (es) 2022-11-30
UY39066A (es) 2021-08-31
EP4103557C0 (en) 2026-02-18
IL295447A (en) 2022-10-01
CN115066422A (zh) 2022-09-16
KR20220140581A (ko) 2022-10-18
BR112022015116A2 (pt) 2022-09-27
US20230382902A1 (en) 2023-11-30
TW202140465A (zh) 2021-11-01
CN115066422B (zh) 2024-11-22
MX2022009804A (es) 2022-09-02
JOP20220180A1 (ar) 2023-01-30
US20210253565A1 (en) 2021-08-19
PE20221576A1 (es) 2022-10-06
CL2022002136A1 (es) 2023-02-03
JP7795466B2 (ja) 2026-01-07
EP4103557A1 (en) 2022-12-21
CA3169988A1 (en) 2021-08-19
AR121296A1 (es) 2022-05-04
CR20220376A (es) 2022-09-16
JP2023512729A (ja) 2023-03-28
CO2022011275A2 (es) 2022-08-30
WO2021160602A1 (en) 2021-08-19
PH12022552019A1 (en) 2023-11-29
DOP2022000162A (es) 2022-10-31
EP4103557B1 (en) 2026-02-18
US11708359B2 (en) 2023-07-25
AU2021220539A1 (en) 2022-10-06

Similar Documents

Publication Publication Date Title
AU2019350624B2 (en) Monoacylglycerol lipase modulators
IL326978A (en) KRAS modulators
EP4103557C0 (en) MONOACYLGLYCEROL LIPASE MODULATORS
GB202018412D0 (en) Malt-1 modulators ii
EP4217062C0 (en) CYCLOBUTYLAMIDE MONOACYLGLYCEROL LIPASE MODULATORS
GB202018150D0 (en) Optical modulator
MA53722A (fr) Modulateurs de la monoacylglycérol lipase
IL285333A (en) Modulators of malat1 expression
IL319572A (en) AKT1 modulators
GB202013282D0 (en) Optical modulator
IL318189A (en) RBM39 heterocyclic modulators
IL287684A (en) trex1 modulators
GB2588284B (en) Optical ring modulator
EP4146666A4 (en) AKT3 MODULATORS
EP4426279A4 (en) AKT3 MODULATORS
EP4146667A4 (en) AKT3 MODULATORS
HK40085115A (en) Monoacylglycerol lipase modulators
AU2024206314A1 (en) Gpr35 modulators
IL319101A (en) Sortilin modulators
IL313360A (en) Modulators of polypeptides
HK40058896A (en) Monoacylglycerol lipase modulators
HK40057796A (en) Monoacylglycerol lipase modulators
EP4146185A4 (en) AKT3 MODULATORS
EP3765009A4 (en) BICYCLIC ROR-GAMMA MODULATORS
GB202018411D0 (en) Malt-1 modulators i